United Kingdom cancer diagnostics market is expected to witness robust growth in the forecast period
United Kingdom cancer diagnostics market is segmented into product, technology, application, end user, regional distribution, and Competitive Landscape.
Based on product, the market is bifurcated into consumables and instruments. Consumables are dominating the market and are expected to maintain their dominance over the next five years owing to the rise in the adoption of consumables for cancer diagnostics and high-end investments for research and development activities. The launch of technologically advanced kits & reagents in the market and the growing old age population are the other prominent drivers expected to drive the segment demand.
Based on technology, the market is divided into IVD testing, imaging, and biopsy. Imaging technology is expected to account for a significant market share in the forecast period. By using imaging technology, healthcare professionals can easily decide the course of action. The constant rise in the number of cancer patients is accelerating the demand for imaging modalities in the country.
GE Healthcare UK Limited, Becton, Dickinson U.K. Limited, Roche Diagnostics UK, Abbott Laboratories Limited, Fujifilm Healthcare UK Limited, Hologic (UK) Limited, Agilent Technologies UK Limited, are the major market players operating in the United Kingdom cancer diagnostics market.
Years considered for this report:Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F-2027F
Objective of the Study:
- To analyze the historical growth in the market size of the United Kingdom Cancer diagnostics market from 2017 to 2021.
- To estimate and forecast the market size of United Kingdom Cancer diagnostics market from 2022E to 2027F and growth rate until 2027F.
- To classify and forecast the United Kingdom Cancer diagnostics market based on product, technology, application, end user, region, and company.
- To identify the dominant region or segment in the United Kingdom Cancer diagnostics market.
- To identify drivers and challenges for the United Kingdom Cancer diagnostics market.
- To examine competitive developments such as expansions, mergers & acquisitions, etc., in the United Kingdom Cancer diagnostics market.
- To identify and analyze the profiles of leading players operating in the United Kingdom Cancer diagnostics market.
- To identify key sustainable strategies adopted by market players in United Kingdom Cancer diagnostics market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of companies across the country. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the comapnies, which could not be identified due to the limitations of secondary research. The publisher analyzed the presence of all major players across the country.
The publisher calculated the market size of the United Kingdom Cancer diagnostics market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the publisher.
Key Target Audience:
- Cancer diagnostics service providers
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to Cancer diagnostics
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, vendor and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
In this report, United Kingdom cancer diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
United Kingdom Cancer Diagnostics Market, By Product:
United Kingdom Cancer Diagnostics Market, By Technology:
- IVD Testing
United Kingdom Cancer Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
United Kingdom Cancer Diagnostics Market, By End User:
- Hospitals & Clinics
- Diagnostic Laboratories
United Kingdom Cancer Diagnostics Market, By Region:
- East Anglia
- East Midlands
- Yorkshire & Humberside
- Rest of United Kingdom
Competitive LandscapeCompany Profiles: Detailed analysis of the major companies present in United Kingdom cancer diagnostics market.
Available Customizations:With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company InformationDetailed analysis and profiling of additional market players (up to five).
Table of Contents
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Consumables v/s Instruments)
6.2.2. By Technology (IVD Testing, Imaging, Biopsy)
6.2.3. By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others)
6.2.4. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Product Market Map
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Antibodies, Kits & Reagents, Probes, Others)
7.2.2. By Application
7.2.3. By End User
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Pathology Instruments, Imaging Instruments, Biopsy Instruments)
8.2.2. By Application
8.2.3. By End User
11.2. Becton, Dickinson U.K. Limited
11.3. Roche Diagnostics UK
11.4. Abbott Laboratories Limited
11.5. Fujifilm Healthcare UK Limited
11.6. Hologic (UK) Limited
11.7. Agilent Technologies UK Limited
A selection of companies mentioned in this report includes:
- GE Healthcare UK Limited
- Becton, Dickinson U.K. Limited
- Roche Diagnostics UK
- Abbott Laboratories Limited
- Fujifilm Healthcare UK Limited
- Hologic (UK) Limited
- Agilent Technologies UK Limited